Medindia

X

Velos Annual Meeting Draws Record Audience for Clinical Research Thought Leadership Presentations and Success Story Sharing

Friday, May 20, 2011 General News J E 4
Advertisement

SAN FRANCISCO, May 20, 2011 /PRNewswire/ -- Velos, Inc. this week hosted a constellation of prestigious academic medical centers, research institutions, investigative leaders and industry partners at its annual meeting in San Francisco. Mark Hagland, Editor-in-Chief of Healthcare Informatics Magazine, delivered the keynote address. Hagland shared insights about current issues in healthcare information management, such as Meaningful Use, HITECH and other elements of the Health Care Reform Act.

Velos customers gathered to discuss a variety of initiatives and to hear speakers from such institutions as the University of Texas MD Anderson Cancer Center, the University of Miami and Duke University. Presenters also included the National Marrow Donor Program, for which Velos is supplying its new Product Fulfillment and Clinical Data Repository (CDR) System. Presenters shared their achievements using Velos eResearch, Velos eIRB and Velos eSample to bring quality and efficiency to programs of clinical research and patient care.

The announcement from Velos to provide 24 x 7 support to their customers was one aspect of an enhanced communications initiative with the Velos user community. Velos unveiled the latest release of their flagship product, Velos eResearch v8.10, which included significant feature enhancements and major improvements to the overall user experience. Several sessions with their customers, who are leaders in clinical research, were focused around future product direction and strategy.

"This year's attendance was higher than at any of our previous conferences," said John S. McIlwain, President and CEO of Velos. "We're delighted to have such a high quality group of professionals participate in this gathering – and to hear them express the fact that they are using the very best system available. It's gratifying to think that Velos can contribute with its ever-advancing systems for medical research."

Velos eResearch customers receive over 50 percent of the NIH extramural medical research funding to the 100 largest such recipients—the largest such share among clinical trial management system software vendors. The Velos eResearch customer base includes 21 top 25 U.S. medical centers and two thirds of the "Honor Roll" in the U.S. News & World Report 2008 Best Hospitals Survey.

About Velos

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S.  Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to participate in a secure, integrated system platform.  System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eTools, a companion product to Velos eResearch, empowers customers by giving them ownership and access to functions such as system configuration, data migrations, custom reporting and third party data submissions.  Founded in 1996, Velos is privately held with headquarters in Fremont, California.  For more information, visit www.velos.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.

SOURCE Velos, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
PROMUS Element™ Stent Demonstrates Exceptional Saf...
S
Brighter.com Brings Quality Dental Care at Lowest ...